PLSE — PULSE BIOSCIENCES, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1625101 ·
Last close
$35.13
Market Cap
$2.43B
52W High
$36.78
52W Low
$18.36
ADV30
385,633
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 264,000 | 4,000 | -18,253,000 | -17,433,000 | 94,539,000 | 80,735,000 | 13,883,000 |
| Sep 2025 | 86,000 | -193,000 | -20,367,000 | -19,385,000 | 108,765,000 | 95,214,000 | 16,071,000 |
| Jun 2025 | 0 | — | -20,275,000 | -19,168,000 | 120,251,000 | 106,349,000 | 15,764,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-55,196,000
Investing CF
$-323,000
Financing CF
$4,559,000
CapEx
$-323,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.10
As of
2026-06-07
Balance + Analyst (yfinance extras)
Retained Earnings
$-481,862,000
Inventory
$206,000
Receivables
$157,000
ST Investments
—
EBIT TTM
$-78,045,000
Pretax Income TTM
$-74,567,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$751,000
EBITDA
$-76,402,000
Free Cash Flow
$-29,080,124
Enterprise Value
$2,370,173,184
Total Cash
$68,319,000
Total Debt
$7,155,000
Shares Out
69,209,712
Trailing EPS
$-1.10
Book Value
$0.97
ROE
-80.7%
ROA
-45.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 350,000 | -76,939,000 | -72,781,000 | 94,539,000 | 13,883,000 | — | -54,122,000 |
| Dec 2024 | 0 | -56,257,000 | -53,585,000 | 132,460,000 | 17,598,000 | — | -36,343,000 |
| Dec 2023 | 0 | -43,574,000 | -42,210,000 | 59,154,000 | 14,794,000 | — | -33,041,000 |
| Dec 2022 | 700,000 | -58,057,000 | -58,505,000 | 77,877,000 | 80,125,000 | — | -47,013,000 |
TTM Snapshot
Revenues TTM
$1,148,000
NetIncome TTM
$-51,071,000
OpCashFlow TTM
$0
Assets (Latest)
$54,249,000
Forward EPS
$-1.09
Max Pain — expiry 2026-08-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $28.00 · spot: $35.13 · call volume: 113 · put volume: 44
Expected Move to 2026-08-21:
±$5.55
(15.80%) —
implied range
$29.58 –
$40.68
· ATM straddle on $35.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LMAT | LEMAITRE VASCULAR INC | $2.32B | $101.32 | — |
| AXGN | Axogen, Inc. | $2.27B | $42.21 | — |
| TMDX | TransMedics Group, Inc. | $2.64B | $76.51 | — |
| XRAY | DENTSPLY SIRONA Inc. | $2.68B | $13.37 | — |
| HTFL | Heartflow, Inc. | $2.18B | $25.23 | — |
News headlines (Yahoo Finance, 1h cache)
Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference
2026-07-30 20:05 · Yahoo
Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study
2026-07-29 11:00 · Yahoo
This Little-Known Biotech Stock Just Hit a New 5-Year High
2026-07-24 14:30 · Yahoo
Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026
2026-07-21 20:05 · Yahoo
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-15 20:05 · Yahoo
Did New Analyst Coverage and Insider Buying Just Shift Pulse Biosciences' (PLSE) Investment Narrative?
2026-06-09 11:08 · Yahoo
Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy
2026-05-26 16:00 · Yahoo
Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.
2026-05-17 15:02 · Yahoo
Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?
2026-05-10 16:08 · Yahoo
Pulse Biosciences Q1 Earnings Call Highlights
2026-05-08 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.